Type II monocytes modulate T cell–mediated central nervous system autoimmune disease (original) (raw)

• Johnson, K.P. et al. Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind, placebo-controlled trial. Neurology 45, 1268–1276 (1995).
  Article CAS Google Scholar
• Neuhaus, O., Farina, C., Wekerle, H. & Hohlfeld, R. Mechanisms of action of glatiramer acetate in multiple sclerosis. Neurology 56, 702–708 (2001).
  Article CAS Google Scholar
• Farina, C., Weber, M.S., Meinl, E., Wekerle, H. & Hohlfeld, R. Glatiramer acetate in multiple sclerosis: update on potential mechanisms of action. Lancet Neurol. 4, 567–575 (2005).
  Article CAS Google Scholar
• Fridkis-Hareli, M. et al. Direct binding of myelin basic protein and synthetic copolymer 1 to class II major histocompatibility complex molecules on living antigen-presenting cells–specificity and promiscuity. Proc. Natl. Acad. Sci. USA 91, 4872–4876 (1994).
  Article CAS Google Scholar
• Teitelbaum, D., Fridkis-Hareli, M., Arnon, R. & Sela, M. Copolymer 1 inhibits chronic relapsing experimental allergic encephalomyelitis induced by proteolipid protein (PLP) peptides in mice and interferes with PLP-specific T cell responses. J. Neuroimmunol. 64, 209–217 (1996).
  Article CAS Google Scholar
• Neuhaus, O. et al. Multiple sclerosis: comparison of copolymer-1- reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells. Proc. Natl. Acad. Sci. USA 97, 7452–7457 (2000).
  Article CAS Google Scholar
• Dhib-Jalbut, S. Mechanisms of action of interferons and glatiramer acetate in multiple sclerosis. Neurology 58, S3–S9 (2002).
  Article CAS Google Scholar
• Duda, P.W., Schmied, M.C., Cook, S.L., Krieger, J.I. & Hafler, D.A. Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis. J. Clin. Invest. 105, 967–976 (2000).
  Article CAS Google Scholar
• Aharoni, R., Teitelbaum, D., Sela, M. & Arnon, R. Copolymer 1 induces T cells of the T helper type 2 that crossreact with myelin basic protein and suppress experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 94, 10821–10826 (1997).
  Article CAS Google Scholar
• Aharoni, R. et al. Specific Th2 cells accumulate in the central nervous system of mice protected against experimental autoimmune encephalomyelitis by copolymer 1. Proc. Natl. Acad. Sci. USA 97, 11472–11477 (2000).
  Article CAS Google Scholar
• Chen, M. et al. Glatiramer acetate induces a Th2-biased response and crossreactivity with myelin basic protein in patients with MS. Mult. Scler. 7, 209–219 (2001).
  Article CAS Google Scholar
• Ziemssen, T., Kumpfel, T., Klinkert, W.E., Neuhaus, O. & Hohlfeld, R. Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy. Brain-derived neurotrophic factor. Brain 125, 2381–2391 (2002).
  Article Google Scholar
• Weber, M.S. et al. Multiple sclerosis: glatiramer acetate inhibits monocyte reactivity in vitro and in vivo. Brain 127, 1370–1378 (2004).
  Article Google Scholar
• Kim, H.J. et al. Type 2 monocyte and microglia differentiation mediated by glatiramer acetate therapy in patients with multiple sclerosis. J. Immunol. 172, 7144–7153 (2004).
  Article CAS Google Scholar
• Vieira, P.L., Heystek, H.C., Wormmeester, J., Wierenga, E.A. & Kapsenberg, M.L. Glatiramer acetate (copolymer-1, copaxone) promotes Th2 cell development and increased IL-10 production through modulation of dendritic cells. J. Immunol. 170, 4483–4488 (2003).
  Article CAS Google Scholar
• Stasiolek, M. et al. Impaired maturation and altered regulatory function of plasmacytoid dendritic cells in multiple sclerosis. Brain 129, 1293–1305 (2006).
  Article Google Scholar
• Stuve, O. et al. Immunomodulatory synergy by combination of atorvastatin and glatiramer acetate in treatment of CNS autoimmunity. J. Clin. Invest. 116, 1037–1044 (2006).
  Article CAS Google Scholar
• Takahashi, K., Prinz, M., Stagi, M., Chechneva, O. & Neumann, H. TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis. PLoS Med. 4, e124 (2007).
  Article Google Scholar
• Zamora, A., Matejuk, A., Silverman, M., Vandenbark, A.A. & Offner, H. Inhibitory effects of incomplete Freund's adjuvant on experimental autoimmune encephalomyelitis. Autoimmunity 35, 21–28 (2002).
  Article CAS Google Scholar
• Kuchroo, V.K. et al. B7–1 and B7–2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80, 707–718 (1995).
  Article CAS Google Scholar
• Ranger, A.M., Das, M.P., Kuchroo, V.K. & Glimcher, L.H. B7–2 (CD86) is essential for the development of IL-4-producing T cells. Int. Immunol. 8, 1549–1560 (1996).
  Article CAS Google Scholar
• Salama, A.D. et al. Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis. J. Exp. Med. 198, 71–78 (2003).
  Article CAS Google Scholar
• Wesemann, D.R. & Benveniste, E.N. STAT-1 alpha and IFN-gamma as modulators of TNF-alpha signaling in macrophages: regulation and functional implications of the TNF receptor 1:STAT-1 alpha complex. J. Immunol. 171, 5313–5319 (2003).
  Article CAS Google Scholar
• Flesch, I.E. et al. Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon gamma and tumor necrosis factor alpha. J. Exp. Med. 181, 1615–1621 (1995).
  Article CAS Google Scholar
• VanDeusen, J.B. et al. STAT-1-mediated repression of monocyte interleukin-10 gene expression in vivo. Eur. J. Immunol. 36, 623–630 (2006).
  Article CAS Google Scholar
• Chitnis, T. et al. Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis. J. Clin. Invest. 108, 739–747 (2001).
  Article CAS Google Scholar
• Mombaerts, P. et al. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68, 869–877 (1992).
  Article CAS Google Scholar
• Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057–1061 (2003).
  Article CAS Google Scholar
• Brunkow, M.E. et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27, 68–73 (2001).
  Article CAS Google Scholar
• Viglietta, V., Baecher-Allan, C., Weiner, H.L. & Hafler, D.A. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 199, 971–979 (2004).
  Article CAS Google Scholar
• Kukreja, A. et al. Multiple immuno-regulatory defects in type-1 diabetes. J. Clin. Invest. 109, 131–140 (2002).
  Article CAS Google Scholar
• Hong, J., Li, N., Zhang, X., Zheng, B. & Zhang, J.Z. Induction of CD4+CD25+ regulatory T cells by copolymer-I through activation of transcription factor Foxp3. Proc. Natl. Acad. Sci. USA 102, 6449–6454 (2005).
  Article CAS Google Scholar
• Putheti, P., Soderstrom, M., Link, H. & Huang, Y.M. Effect of glatiramer acetate (Copaxone) on CD4+CD25high T regulatory cells and their IL-10 production in multiple sclerosis. J. Neuroimmunol. 144, 125–131 (2003).
  Article CAS Google Scholar
• Aharoni, R., Teitelbaum, D., Sela, M. & Arnon, R. Bystander suppression of experimental autoimmune encephalomyelitis by T cell lines and clones of the Th2 type induced by copolymer 1. J. Neuroimmunol. 91, 135–146 (1998).
  Article CAS Google Scholar
• Harrington, L.E. et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6, 1123–1132 (2005).
  Article CAS Google Scholar
• Bettelli, E. et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235–238 (2006).
  Article CAS Google Scholar
• Shimoda, M. et al. Conditional ablation of MHC-II suggests an indirect role for MHC-II in regulatory CD4 T cell maintenance. J. Immunol. 176, 6503–6511 (2006).
  Article CAS Google Scholar
• Steinman, L. & Zamvil, S.S. How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis. Ann. Neurol. 60, 12–21 (2006).
  Article CAS Google Scholar
• Nestle, F.O. Dendritic cell vaccination for cancer therapy. Oncogene 19, 6673–6679 (2000).
  Article CAS Google Scholar
• Frisullo, G. et al. pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity. J. Neurosci. Res. 84, 1027–1036 (2006).
  Article CAS Google Scholar
• Tran, E.H., Hoekstra, K., van Rooijen, N., Dijkstra, C.D. & Owens, T. Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice. J. Immunol. 161, 3767–3775 (1998).
  CAS PubMed Google Scholar
• Jee, Y. et al. Do Th2 cells mediate the effects of glatiramer acetate in experimental autoimmune encephalomyelitis? Int. Immunol. 18, 537–544 (2006).
  Article CAS Google Scholar
• Lisak, R.P., Zweiman, B., Blanchard, N. & Rorke, L.B. Effect of treatment with Copolymer 1 (Cop-1) on the in vivo and in vitro manifestations of experimental allergic encephalomyelitis (EAE). J. Neurol. Sci. 62, 281–293 (1983).
  Article CAS Google Scholar
• Thornton, A.M. & Shevach, E.M. Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J. Immunol. 164, 183–190 (2000).
  Article CAS Google Scholar
• Zamvil, S. et al. T cell clones specific for myelin basic protein induce relapsing EAE and demyelination. Nature 317, 355–358 (1985).
  Article CAS Google Scholar
• Zhang, M. et al. Copolymer 1 inhibits experimental autoimmune uveoretinitis. J. Neuroimmunol. 103, 189–194 (2000).
  Article CAS Google Scholar
• Gur, C. et al. Amelioration of experimental colitis by Copaxone is associated with class-II-restricted CD4 immune blocking. Clin. Immunol. 118, 307–316 (2006).
  Article CAS Google Scholar
• Arnon, R. & Aharoni, R. Mechanism of action of glatiramer acetate in multiple sclerosis and its potential for the development of new applications. Proc. Natl. Acad. Sci. USA 101(suppl. 2), 14593–14598 (2004).
  Article CAS Google Scholar
• Hardardottir, F., Baron, J.L. & Janeway, C.A., Jr. T cells with two functional antigen-specific receptors. Proc. Natl. Acad. Sci. USA 92, 354–358 (1995).
  Article CAS Google Scholar
• Bettelli, E. et al. Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J. Exp. Med. 197, 1073–1081 (2003).
  Article CAS Google Scholar